Latest News about RHHBY
Recent news which mentions RHHBY
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
From Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
From Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
October 28, 2023
From Motley Fool
From Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
October 23, 2023
From InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
October 23, 2023
From Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023
From MarketWatch
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
From Motley Fool
From MarketWatch
From Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
October 17, 2023
From Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
From Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
From Benzinga
Tempest Therapeutics shares head back to earth after 4,000% gain
October 12, 2023
From MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
October 11, 2023
From InvestorPlace
From Benzinga
From MarketWatch
From Benzinga
From InvestorPlace
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
From Motley Fool
Ionis-Roche Join Forces To Compete In Neurodegenerative Disease Space, Analyst Sees Short-Term Challenges
September 27, 2023
From Benzinga
AI To Revolutionize Clinical Trials And Diagnostics
September 22, 2023
From Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
September 21, 2023
From Benzinga
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
September 13, 2023
From InvestorPlace
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
September 12, 2023
From Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
September 11, 2023
From Benzinga
Recursion Pharmaceuticals has a prescription for high drug costs: AI and 25 petabytes of data
September 08, 2023
From MarketWatch
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
September 07, 2023
From Benzinga
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
September 01, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.